• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETIHX:US

20.53 USD 0.26 1.28%

As of 09:29:30 ET on 12/24/2014.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETIHX)

Year To Date: +26.11% 3-Month: +20.27% 3-Year: - 52-Week Range: 14.38 - 21.19
1-Month: +8.22% 1-Year: +26.03% 5-Year: - Beta vs SPX: 0.95

Mutual Fund Chart for ETIHX

No chart data available.
  • ETIHX:US 20.53
  • 1M
  • 1Y
Interactive ETIHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETIHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETIHX

NAV (on 2014-12-24) 20.53
Assets (M) (on 2014-12-24) 144.88
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 50.00

Dividends for ETIHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETIHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.43

Top Fund Holdings for ETIHX

Filing Date: 09/30/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 75,100 4,607,385 4.224%
Medivation Inc 41,500 4,103,105 3.762%
Dyax Corp 303,000 3,066,360 2.811%
Tetraphase Pharmaceuticals Inc 149,900 2,990,505 2.742%
Ultragenyx Pharmaceutical Inc 52,600 2,977,160 2.729%
Chimerix Inc 106,600 2,944,292 2.699%
Bluebird Bio Inc 76,900 2,759,172 2.530%
AbbVie Inc 47,000 2,714,720 2.489%
Celgene Corp 26,000 2,464,280 2.259%
Veracyte Inc 240,600 2,345,850 2.151%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil